Company Nodişanamed S.r.l. with Fiscal Code 36787690
recorded a turnover of 2024 of
26.006,
with a net profit of
-2.122
and having an average number of employees of
- .
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Nodişanamed S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
7.553
8.561
10.351
11.088
13.693
12.669
14.182
26.006
Total Income - EUR
-
-
7.553
8.561
10.351
11.088
13.693
14.631
14.182
30.832
Total Expenses - EUR
-
-
5.814
9.841
5.586
6.323
8.296
10.508
9.750
31.939
Gross Profit/Loss - EUR
-
-
1.739
-1.280
4.765
4.765
5.396
4.123
4.432
-1.106
Net Profit/Loss - EUR
-
-
1.364
-1.366
4.454
4.433
4.985
3.751
3.877
-2.122
Employees
-
-
1
1
0
0
0
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 84.4%, from 14.182 euro in the year 2023, to 26.006 euro in 2024.
The Net Profit decreased by -3.855 euro, from 3.877 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Nodişanamed S.r.l.
Financial Rating - NODIŞANAMED S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Nodişanamed S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Nodişanamed S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Nodişanamed S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
11.341 euro in 2024 which includes Inventories of
0 euro, Receivables of
4.030 euro and cash availability of
7.312 euro.
The company's Equity was valued at
9.639 euro, while total Liabilities amounted to
37.307 euro.
Equity decreased by -5.439 euro, from 15.162 euro in 2023, to 9.639 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Nodişanamed S.r.l.